
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
CRISP-3 CRISPR/Cas9 KO Plasmid (m) | sc-419036 | 20 µg | $397.00 |
Crisp3 encodes cysteine-rich secretory protein 3 (CRISP-3), a secreted CAP superfamily member implicated in extracellular signaling and modulation of immune and epithelial cell interactions. CRISP-3 is enriched in exocrine and mucosal tissues and has been linked to regulation of protease activity, antimicrobial defense, and inflammatory cues within the local microenvironment. Through its extracellular localization, CRISP-3 can influence tissue remodeling and innate immune processes that intersect with wound response and barrier function pathways. Dysregulated CRISP-3 expression has been reported in inflammation-associated contexts and cancer-related transcriptomic signatures, making Crisp3 a useful node for studying microenvironmental regulation and secreted factor biology in mouse models.
CRISP-3 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Crisp3 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Crisp3 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Crisp3 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish CRISP-3 protein expression.
This CRISPR knockout system enables efficient generation of Crisp3-deficient cell models for investigation of CRISP-3 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.